Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors.  Behavioural Brain Research.  373. 2019
2019 Klotho deficiency affects the spine morphology and network synchronization of neurons.  Molecular and Cellular Neuroscience.  98:1-11. 2019
2019 Dendritic spine remodeling accompanies Alzheimer's disease pathology and genetic susceptibility in cognitively normal aging.  Neurobiology of Aging.  73:92-103. 2019
2019 Pharmacologic inhibition of LIMK1 provides dendritic spine resilience against β-amyloid.  Science Signaling.  12. 2019
2019 The SETD6 Methyltransferase Plays an Essential Role in Hippocampus-Dependent Memory Formation.  Biological Psychiatry.  2019
2018 Distinct and complementary functions of rho kinase isoforms ROCK1 and ROCK2 in prefrontal cortex structural plasticity.  Zeitschrift fur Anatomie und Entwicklungsgeschichte.  223:4227-4241. 2018
2018 α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons.  Acta Neuropathologica Communications.  6:35. 2018
2017 Dendritic spines provide cognitive resilience against Alzheimer's disease.  Annals of Neurology.  82:602-614. 2017
2016 Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.  Journal of Neurochemistry.  525-531. 2016
2016 Rho kinase inhibition as a therapeutic for progressive supranuclear palsy and corticobasal degeneration.  Journal of Neuroscience.  36:1316-1323. 2016
2013 Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model.  Journal of Neuroscience.  33:19086-19098. 2013
2013 AAV2 production with optimized N/P ratio and PEI-mediated transfection results in low toxicity and high titer for in vitro and in vivo applications.  Journal of Virological Methods.  193:270-277. 2013
2013 RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells.  Neurobiology of Disease.  54:264-279. 2013
2012 Neuronal LR11 expression does not differentiate between clinically-defined Alzheimer's disease and control brains.  PLoS ONE.  7. 2012
2012 Asparaginyl endopeptidase cleaves TDP-43 in brain.  Proteomics.  12:2455-2463. 2012
2012 GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β production.  Cell regulation.  23:2645-2657. 2012
2012 Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards.  Journal of Proteome Research.  11:2721-2738. 2012
2012 Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling.  Journal of Neuroinflammation.  9. 2012
2011 The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells (Journal of Virology (2005) 79, 4, (2261-2273)).  Journal of Virology.  85:3041. 2011
2011 Rho kinase II phosphorylation of the lipoprotein receptor LR11/SORLA alters amyloid-β production.  Journal of Biological Chemistry.  286:6117-6127. 2011
2010 Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration.  Journal of Proteome Research.  9:6368-6379. 2010
2008 Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection.  Journal of Virology.  82:3295-3310. 2008
2008 The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation.  PLoS Pathogens.  4. 2008
2005 The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells.  Journal of Virology.  79:2261-2273. 2005

Research Overview

  • Our team conducts research on Alzheimer’s disease (AD) and Frontotemporal dementia (FTD) and is committed to identifying better therapeutic targets and finding more effective treatments for these devastating disorders. We formulate and test mechanistic hypotheses on AD and FTD pathogenesis by incorporating cellular and animal models with synergistic studies using postmortem human brain tissue samples. The lab addresses basic science questions and performs preclinical studies on therapeutic targets for AD and FTD.

    • Principal Investigator On

    Investigator On

    Education And Training

  • Doctor of Philosophy in Microbiology, Emory University 2007

    • Full Name

  • Jeremy Herskowitz